These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 18166993
1. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Denecke J, Kranz C, Nimtz M, Conradt HS, Brune T, Heimpel H, Marquardt T. Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993 [Abstract] [Full Text] [Related]
2. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis. Fukuda MN. Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936 [Abstract] [Full Text] [Related]
3. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase. Fukuda MN, Masri KA, Dell A, Thonar EJ, Klier G, Lowenthal RM. Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036 [Abstract] [Full Text] [Related]
4. Short report: erythrocyte membranes from a patient with congenital dyserythropoietic anaemia type I (CDA-I) show identical, although less pronounced, glycoconjugate abnormalities to those from patients with CDA-II (HEMPAS). Zdebska E, Woźniewicz B, Adamowicz-Salach A, Kościelak J. Br J Haematol; 2000 Sep; 110(4):998-1001. PubMed ID: 11054095 [Abstract] [Full Text] [Related]
5. Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II). Mawby WJ, Tanner MJ, Anstee DJ, Clamp JR. Br J Haematol; 1983 Oct; 55(2):357-68. PubMed ID: 6615729 [Abstract] [Full Text] [Related]
6. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers. Zdebska E, Mendek-Czajkowska E, Ploski R, Woêniewicz B, Koscielak J. Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161 [Abstract] [Full Text] [Related]
7. Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III. Zdebska E, Gołaszewska E, Fabijańska-Mitek J, Schachter H, Shalev H, Tamary H, Sandström H, Wahlin A, Kościelak J. Br J Haematol; 2001 Sep; 114(4):907-13. PubMed ID: 11564084 [Abstract] [Full Text] [Related]
9. Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. De Franceschi L, Turrini F, del Giudice EM, Perrotta S, Olivieri O, Corrocher R, Mannu F, Iolascon A. Exp Hematol; 1998 Aug 08; 26(9):869-73. PubMed ID: 9694508 [Abstract] [Full Text] [Related]
11. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. Fukuda MN, Dell A, Scartezzini P. J Biol Chem; 1987 May 25; 262(15):7195-206. PubMed ID: 2953718 [Abstract] [Full Text] [Related]
12. Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated. Zdebska E, Adamczyk-Popławska M, Kościelak J. Acta Biochim Pol; 2000 May 25; 47(3):773-9. PubMed ID: 11310976 [Abstract] [Full Text] [Related]
14. Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. Küster B, Hunter AP, Wheeler SF, Dwek RA, Harvey DJ. Electrophoresis; 1998 Aug 25; 19(11):1950-9. PubMed ID: 9740055 [Abstract] [Full Text] [Related]
15. Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene. Zdebska E, Iolascon A, Spychalska J, Perrotta S, Lanzara C, Smolenska-Sym G, Koscielak J. Haematologica; 2007 Mar 25; 92(3):427-8. PubMed ID: 17339199 [Abstract] [Full Text] [Related]
16. Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): where are we now? Denecke J, Marquardt T. Biochim Biophys Acta; 2009 Sep 25; 1792(9):915-20. PubMed ID: 19150496 [Abstract] [Full Text] [Related]
17. Comparison of planar SDS-PAGE, CGE-on-a-chip, and MALDI-TOF mass spectrometry for analysis of the enzymatic de-N-glycosylation of antithrombin III and coagulation factor IX with PNGase F. Müller R, Marchetti M, Kratzmeier M, Elgass H, Kuschel M, Zenker A, Allmaier G. Anal Bioanal Chem; 2007 Nov 25; 389(6):1859-68. PubMed ID: 17879089 [Abstract] [Full Text] [Related]
18. Anomalous clustering of underglycosylated band 3 in erythrocytes and their precursor cells in congenital dyserythropoietic anemia type II. Fukuda MN, Klier G, Yu J, Scartezzini P. Blood; 1986 Aug 25; 68(2):521-9. PubMed ID: 3730615 [Abstract] [Full Text] [Related]
19. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B. Haematologica; 1996 Aug 25; 81(6):543-59. PubMed ID: 9009444 [Abstract] [Full Text] [Related]
20. Erythrocyte membrane proteins in an unusual case of congenital dyserythropoietic anaemia type II (CDA II). Harlow RW, Lowenthal RM. Br J Haematol; 1982 Jan 25; 50(1):35-41. PubMed ID: 7055536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]